Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy

Mesenchymal Stem Cell Therapy in Diabetic Cardiomyopathy

The incidence and prevalence of diabetes mellitus (DM) are increasing worldwide, and the resulting cardiac complications are the leading cause of death. Among these complications is diabetes-induced cardiomyopathy (DCM), which is the consequence of a pro-inflammatory condition, oxidative stress and...

Full description

Bibliographic Details
Main Authors: Jaqueline S. da Silva, Renata G. J. Gonçalves, Juliana F. Vasques, Bruna S. Rocha, Bianca Nascimento-Carlos, Tadeu L. Montagnoli, Rosália Mendez-Otero, Mauro P. L. de Sá, Gisele Zapata-Sudo
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Cells
Subjects:
diabetes mellitus
cardiac remodeling
diabetic cardiomyopathy
mesenchymal stromal cells
pro-inflammatory cytokines
oxidative stress
Online Access:https://www.mdpi.com/2073-4409/11/2/240

Internet

https://www.mdpi.com/2073-4409/11/2/240

Similar Items